Clinical Trials Directory

Trials / Completed

CompletedNCT00115479

KULeuven Intensive Insulin Therapy Study in Medical Intensive Care Patients

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
1,200 (planned)
Sponsor
KU Leuven · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In a previous study, we showed that tight blood glucose control with insulin during intensive care reduced morbidity and mortality of surgical intensive care patients. Whether this intervention also improves prognosis of medical intensive care patients remains unknown. The current prospective, randomized, controlled study will assess the impact of intensive insulin therapy on the outcome of patients in a medical intensive care unit. On admission, patients will be randomly assigned to either strict normalization of blood glucose (80-110 mg/dl) with intensive insulin therapy or the conventional approach, in which insulin infusion is initiated only when blood glucose exceeds 215 mg/dl, to maintain blood glucose levels between 180 and 200 mg/dl.

Detailed description

In a previous study, we showed that tight blood glucose control with insulin during intensive care reduced morbidity and mortality of surgical intensive care patients. Whether this intervention also improves prognosis of medical intensive care patients remains unknown. The current prospective, randomized, controlled study will assess the impact of intensive insulin therapy on the outcome of patients in a medical intensive care unit. On admission, patients will be randomly assigned to either strict normalization of blood glucose (80-110 mg/dl) with intensive insulin therapy or the conventional approach, in which insulin infusion is initiated only when blood glucose exceeds 215 mg/dl, to maintain blood glucose levels between 180 and 200 mg/dl.

Conditions

Interventions

TypeNameDescription
DRUGintensive insulin therapy to maintain normoglycemia

Timeline

Start date
2002-03-01
Completion
2005-06-01
First posted
2005-06-23
Last updated
2006-05-04

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT00115479. Inclusion in this directory is not an endorsement.